NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 203 filers reported holding NEVRO CORP in Q2 2017. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $82,000 | -20.4% | 1,102 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $103,000 | +18.4% | 1,102 | -8.2% | 0.00% | 0.0% |
| Q4 2016 | $87,000 | -30.4% | 1,201 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $125,000 | -17.8% | 1,201 | -41.6% | 0.00% | 0.0% |
| Q2 2016 | $152,000 | +31.0% | 2,055 | 0.0% | 0.00% | +50.0% |
| Q1 2016 | $116,000 | -16.5% | 2,055 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $139,000 | – | 2,055 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |